BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22542810)

  • 1. Up-regulation of endogenous PML induced by a combination of interferon-beta and temozolomide enhances p73/YAP-mediated apoptosis in glioblastoma.
    Okazaki T; Kageji T; Kuwayama K; Kitazato KT; Mure H; Hara K; Morigaki R; Mizobuchi Y; Matsuzaki K; Nagahiro S
    Cancer Lett; 2012 Oct; 323(2):199-207. PubMed ID: 22542810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop.
    Lapi E; Di Agostino S; Donzelli S; Gal H; Domany E; Rechavi G; Pandolfi PP; Givol D; Strano S; Lu X; Blandino G
    Mol Cell; 2008 Dec; 32(6):803-14. PubMed ID: 19111660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein.
    Xu Z; Chen J; Shao L; Ma W; Xu D
    Tumour Biol; 2015 Sep; 36(10):8047-54. PubMed ID: 25971581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
    Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
    Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.
    Kuwayama K; Matsuzaki K; Mizobuchi Y; Mure H; Kitazato KT; Kageji T; Nakao M; Nagahiro S
    Neuro Oncol; 2009 Apr; 11(2):132-41. PubMed ID: 18812519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP and p73: a complex affair.
    Downward J; Basu S
    Mol Cell; 2008 Dec; 32(6):749-50. PubMed ID: 19111652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells.
    Happold C; Roth P; Silginer M; Florea AM; Lamszus K; Frei K; Deenen R; Reifenberger G; Weller M
    Mol Cancer Ther; 2014 Apr; 13(4):948-61. PubMed ID: 24526161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis.
    Sato A; Sunayama J; Matsuda K; Seino S; Suzuki K; Watanabe E; Tachibana K; Tomiyama A; Kayama T; Kitanaka C
    Stem Cells; 2011 Dec; 29(12):1942-51. PubMed ID: 21957016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
    Okada M; Sato A; Shibuya K; Watanabe E; Seino S; Suzuki S; Seino M; Narita Y; Shibui S; Kayama T; Kitanaka C
    Int J Oncol; 2014 Feb; 44(2):591-9. PubMed ID: 24316756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.
    Strano S; Monti O; Pediconi N; Baccarini A; Fontemaggi G; Lapi E; Mantovani F; Damalas A; Citro G; Sacchi A; Del Sal G; Levrero M; Blandino G
    Mol Cell; 2005 May; 18(4):447-59. PubMed ID: 15893728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51.
    Xipell E; Aragón T; Martínez-Velez N; Vera B; Idoate MA; Martínez-Irujo JJ; Garzón AG; Gonzalez-Huarriz M; Acanda AM; Jones C; Lang FF; Fueyo J; Gomez-Manzano C; Alonso MM
    Neuro Oncol; 2016 Aug; 18(8):1109-19. PubMed ID: 26951384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
    Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
    Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
    Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
    Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling.
    Yuki K; Natsume A; Yokoyama H; Kondo Y; Ohno M; Kato T; Chansakul P; Ito M; Kim SU; Wakabayashi T
    Cancer Lett; 2009 Oct; 284(1):71-9. PubMed ID: 19457609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.